SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, bz777, UndervaluedStocks, HighYieldStocks
Search This Board: 
Last Post: 5/24/2017 8:57:08 PM - Followers: 397 - Board type: Free - Posts Today: 0



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#46022  Sticky Note Audit completed!!! Waiting and watching for 10K! techmover 05/16/17 03:05:57 PM
#45802  Sticky Note If you are new to the ARYC board, UndervaluedStocks 05/10/17 02:54:43 PM
#45708  Sticky Note NEW...Arrayit to double manufacturing capacity by 6/30/2017 to HighYieldStocks 05/08/17 11:49:19 AM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates StockZoom 02/08/17 10:32:34 AM
#46441   I tried as well with the same result. Delsurfer 05/24/17 08:57:08 PM
#46440   Has anyone had any luck getting a reply So des ne 05/24/17 08:36:51 PM
#46438   That would be fantastic, thank you UndervaluedStocks 05/24/17 06:21:36 PM
#46437   With any luck I'll unload my last 300k nobodysmoney 05/24/17 06:16:25 PM
#46434   Aryc does not pay its obligations and its Hugie 05/24/17 04:26:25 PM
#46433   Aryc can be also in the process of Hugie 05/24/17 04:23:35 PM
#46432   Haha... Not gonna happen... Buckstopshere 05/24/17 04:23:11 PM
#46431   Shorters' Actions Can Promote a Healthy Market at UndervaluedStocks 05/24/17 04:20:25 PM
#46430   For being delayed on filing? Contact RRBB for UndervaluedStocks 05/24/17 04:16:23 PM
#46428   How much longer until the sec suspends trading Hugie 05/24/17 04:09:10 PM
#46427   Payment on the $1.6 million loan was due MikeCr 05/24/17 04:08:38 PM
#46426   And a lawsuit would have been filed by now! Buckstopshere 05/24/17 04:04:37 PM
#46425   If that was the case you would already Buckstopshere 05/24/17 04:03:59 PM
#46424   Or they could default on the TCA loan MikeCr 05/24/17 04:00:32 PM
#46423   That's the rub, nobody knows what happened. It's MikeCr 05/24/17 03:58:32 PM
#46422   TCA don't care about the Q1 they want Buckstopshere 05/24/17 03:54:20 PM
#46421   I have been holding ARYC shares since 2012. Bulldog09 05/24/17 03:53:30 PM
#46420   Nobody knows what's happen between TCA and ARYC Buckstopshere 05/24/17 03:43:54 PM
#46419   No, that was barring any unforeseen events. Back techmover 05/24/17 03:43:31 PM
#46418   Do you see any dilution? Buckstopshere 05/24/17 03:36:29 PM
#46417   The 8K from December said they had 90 MikeCr 05/24/17 03:30:52 PM
#46416   They never gave a specific date... Buckstopshere 05/24/17 03:22:29 PM
#46415   I guess that Aryc will never release any Hugie 05/24/17 03:13:00 PM
#46414   NEW...Arrayit microarray customer $19B Agilent NYSE:A beat and HighYieldStocks 05/24/17 02:36:46 PM
#46413   Same :) Shook a weak hand today. Good riddance UndervaluedStocks 05/24/17 02:34:51 PM
#46412   all I see is lousy spreads still with JB3136 05/24/17 02:34:27 PM
#46411   ???? You've been watching Aryc for a while... Buckstopshere 05/24/17 02:32:24 PM
#46410   Congrats to any that picked up some super Buckstopshere 05/24/17 02:29:42 PM
#46409   what fins? when was the last time they JB3136 05/24/17 02:25:05 PM
#46408   Agree, holding long and strong! Penny Traders Club 05/24/17 02:19:07 PM
#46407   Nobody that has any brains believed that prediction. Buckstopshere 05/24/17 02:17:35 PM
#46406   the prediction of filings backfired. lucky,mydog 05/24/17 01:59:44 PM
#46405   If it even gets there... Aryc has been Buckstopshere 05/24/17 01:59:18 PM
#46403   It is only twitter,We miss any proof... Hugie 05/24/17 01:57:01 PM
#46402   It doesn't matter for the market as long jrsh 05/24/17 01:56:59 PM
#46401   It won't go below .0035... Buckstopshere 05/24/17 01:53:30 PM
#46400   ARYC is going down to 0,001-0,002 to buy Hugie 05/24/17 01:37:56 PM
#46399   Sales and RFQ's from the past week ARYC UndervaluedStocks 05/24/17 01:36:45 PM
#46398   Don't thank me, thank Arrayit management for not MikeCr 05/24/17 01:21:46 PM
#46397   NEW...Arrayit reports microarray technology inquiry from advanced genomics HighYieldStocks 05/24/17 01:15:00 PM
#46396   NEW...Arrayit reports $75,000 microarray instrument inquiry from top HighYieldStocks 05/24/17 01:10:09 PM
#46395   NEW...Arrayit reports $18,300 microarray services sale to a HighYieldStocks 05/24/17 12:59:47 PM
#46394   Everybody who want will have still very good Hugie 05/24/17 12:52:30 PM
#46393   NEW...Arrayit 259K twitter followers compare favorably with $67.2B HighYieldStocks 05/24/17 12:10:44 PM
#46392   NEW...Arrayit reports $29,800 microarray services sale to a HighYieldStocks 05/24/17 12:10:36 PM
#46391   Right now it is just 160k all the jrsh 05/24/17 11:50:03 AM
#46390   Yessir. :) UndervaluedStocks 05/24/17 11:43:33 AM
#46389   You see this is a problem since weeks, jrsh 05/24/17 11:42:50 AM
#46388   Congrats to whoever took advantage of the weak hands....ARYC UndervaluedStocks 05/24/17 11:42:17 AM
#46387   lvl2 down to 5 mm's joever 05/24/17 11:37:40 AM